Tag: Clinical Trials

Sam Altman, CEO of OpenAI and Chairman of Journey Colab is working to make groundbreaking advances in mental health available to all. With All Points North rehab clinic, he is conducting clinical trials of MDMA, Psilocybin, and other potential treatments for mental health and addiction. Journey Colab is advancing access to psychedelics, potentially leading to a revolutionary shift in mental health. OpenAI is a global leader in AI research & development, with a goal to make AI available to everyone. Altman's ChatGPT powered AI, has already brought progress for those in need of mental health aid. Let's revolutionize mental health care!

Little Journey, a London-based startup, raised $3.1 million to reduce a child's anxiety while undergoing clinical trials & hospital procedures. Their revolutionary platform offers an app that simplifies medical terms, uses personalized care & animated characters to explain procedures. Octopus Ventures was the lead investor. Dr. Chris Evans, the founder, is dedicated to making care more efficient, equitable and patient-centred.

This article covers the new Artificial Intelligence (AI) model developed to bring clarity to doctors in delivering prognoses and deciding on treatments for colorectal cancer patients. MOMA, the AI platform designed to detect and interpret visual patterns clinicians can't, has been tested on nearly 2000 patients to accurately predict how aggressive the tumor is, how likely the patient is to survive and respond to differing therapies. Improve accuracy and save lives with this AI-empowered diagnosis platform.

AlphaPrime is a global health technology comp. founded in 2020 by Sharon Chen, offering suite of products covering entire clinical trials cycle with emphasis on intelligent design & analysis. With its SaaS platform & powerful EDC tool, AlphaPrime helps customers finish clinical trials faster & supports development & commercialization of consumer products. Secured A+ financing led by Han Kang Cap & B Cap. Expanding presence in US, EU, & Australia/Southeast Asian countries.

Jordan W. Squair has just won the 2023 BioInnovation Institute & Science Award for Innovation. He has developed a neuroprosthetic baroreflex that helps treat very low blood pressure in patients with spinal cord injuries. This tech can also monitor BP with each heartbeat, providing accurate data for healthcare professionals.